Biomerieux Logo

SCCM 2012 Survey Results

The bioMérieux Sepsis Survey Project surveyed and interviewed 187 critical care specialists at the 2012 Society of Critical Care Medicine (SCCM) conference. bioMérieux has been tracking sepsis prevalence trends and surveyed thousands of doctors, nurses and pharmacists over five years.

1) Are you familiar with PCT as a new biomarker to aid in the diagnosis of sepsis?

Yes 149
No 28

2) If a test were available that could help you determine in less than 30 minutes that the cause of an infection is viral, rather than a severe bacterial infection, would you find the test:

A dramatic improvement in care 112
A good tool, but not essential 56
A diagnostic you would not typically use 6

3) Have you ever ordered a PCT test for a patient in the ICU?

Yes 70
No 106

4) If yes, how do you use these (PCT) results?

To stratify risk of sepsis and septic shock 70
To select drug therapy 15
To discontinue antibiotic treatment 30
Other 0

5) Circle the answers that describe the sepsis trend among your CC patients over the last 12 months:

Increasing 92
Decreasing 13
Affecting Younger Patients 34
No Change 56

6) If you have seen an increase in sepsis, to what do you attribute this trend?

Medical and technological advances associated with treatments 52
Increasing number of elderly, immunocompromised patients 62
Antibiotic resistance 54

7) If a biomarker test could be used to monitor the progression of sepsis over 24 hours, would use see it as beneficial?

Yes 174
No 4

8) In the treatment of a likely sepsis patient, circle the answer below that best describes the impact on patient care if you had positive organism ID within minutes of positve blood culture:

Dramatic improvement in care 144
Moderate impact 32
No impact 3

9) In an infection that likely will lead to sepsis could be identified by your mirco lab 12-24 hrs faster, what would be the impact on treatment?

I would use the information to select the best possible therapy 110
I would reduce usage of broad spectrum abx with this information 76
This could significantly improve the treatment of my sepsis patients and improve outcomes 35
Without rapid AST, this would be helpful but would not impact outcomes 7
Unknown 3

10) Is rapid microbial ID helpful in the treatment of sepsis without immediate AST data?

Yes 147
No 14

11) Why do same-day AST matter to you?

Help guide therapy 109
Correct incorrect treatment decisions 45
Avert misuse and overuse of abx 77

12) Are you aware of research into technologies, such as as MS, that hold the potential to significantly speed up the identification of infection?

Yes 78
No 87

13) Are you familiar with MALDI-TOF MS and its potential to speed up infection ID from days to hours?

Yes 23
No 141

14) Select the answer below that best describes your assessment of abx resistance in the ICU:

To blame for increasing fatalities last 2 years 30
Significant problem in the ICU 101
Serious but manageable problem 25
Insignificant 2


Watch the inspiring video of sepsis survivor Patricia Cragen and her family as they experience a once in a lifetime event at Strike Out Sepsis Day with the St. Louis Cardinals on August 31, 2015. Watch Video >

See highlights from the Second National Forum on Sepsis, held September 16, 2015 in Washington, DC, and learn more about the Rory Staunton Foundation’s initiatives to raise awareness and knowledge about sepsis. Watch Video >


  • VIDAS® B•R•A•H•M•S PCT™ for the Clinician - Download
  • Procalcitonin: A Novel Biomarker for Bacterial Infections and Sepsis - Download
  • Procalcitonin Over Time - Download
  • Blood Culture: A Key Investigation for Diagnosis of Bloodstream Infections - Download